132 related articles for article (PubMed ID: 10586201)
21. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
[TBL] [Abstract][Full Text] [Related]
22. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.
MacDonald AS;
Transplantation; 2001 Jan; 71(2):271-80. PubMed ID: 11213073
[TBL] [Abstract][Full Text] [Related]
23. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice.
Zhu J; Liu Y; Pi Y; Jia L; Wang L; Huang Y
Acta Ophthalmol; 2014 Feb; 92(1):e12-21. PubMed ID: 23910624
[TBL] [Abstract][Full Text] [Related]
24. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
25. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
Chen H; Wu J; Xu D; Luo H; Daloze PM
Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
[TBL] [Abstract][Full Text] [Related]
26. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
[TBL] [Abstract][Full Text] [Related]
27. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
Thompson P; Xu D; Brunette I; Chen H
Transplant Proc; 1998 Jun; 30(4):1033-5. PubMed ID: 9636417
[No Abstract] [Full Text] [Related]
28. Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival.
Stanojlovic S; Schlickeiser S; Appelt C; Vogt K; Schmitt-Knosalla I; Haase S; Ritter T; Sawitzki B; Pleyer U
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1447-56. PubMed ID: 20574747
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
Longoria J; Roberts RF; Marboe CC; Stouch BC; Starnes VA; Barr ML
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):714-8. PubMed ID: 10096966
[TBL] [Abstract][Full Text] [Related]
30. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
31. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival.
Hamashima T; Stepkowski SM; Chou TC; Kahan BD
Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.
Velosa JA; Larson TS; Gloor JM; Stegall MD
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S3-S10. PubMed ID: 11583938
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
Johnson RW; Kreis H; Oberbauer R; Brattström C; Claesson K; Eris J
Transplantation; 2001 Sep; 72(5):777-86. PubMed ID: 11571437
[TBL] [Abstract][Full Text] [Related]
34. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection].
Dong Y; Huang YF; Wang LQ; Chen B
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181
[TBL] [Abstract][Full Text] [Related]
35. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
[TBL] [Abstract][Full Text] [Related]
36. Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection.
Reis A; Megahed M; Reinhard T; Godehardt E; Braunstein C; Sundmacher R
Cornea; 2002 Jan; 21(1):81-4. PubMed ID: 11805513
[TBL] [Abstract][Full Text] [Related]
37. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
Stepkowski SM; Tu Y; Chou TC; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
[No Abstract] [Full Text] [Related]
38. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
Koehl GE; Andrassy J; Guba M; Richter S; Kroemer A; Scherer MN; Steinbauer M; Graeb C; Schlitt HJ; Jauch KW; Geissler EK
Transplantation; 2004 May; 77(9):1319-26. PubMed ID: 15167584
[TBL] [Abstract][Full Text] [Related]
39. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
[No Abstract] [Full Text] [Related]
40. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
